Sanofi Ends Marketing Deal With Developer of Inhaled Insulin - New York Times

Sanofi Ends Marketing Deal With Developer of Inhaled Insulin - New York Times | marketing - Google News | January 05, 2016 at 03:06PM

New York Times

Sanofi Ends Marketing Deal With Developer of Inhaled Insulin New York Times MannKind, the developer of the insulin, announced on Tuesday that Sanofi, the big French drug company with the marketing rights, was terminating the agreement between the two companies. The move by Sanofi was not a surprise since the inhaled insulin, ... Sanofi to stop marketing Afrezza, citing low RxMedical Marketing and Media MannKind plans to seek new marketing partner for insulin drugLos Angeles Times all 70 news articles »

January 05, 2016 at 03:06PM | marketing - Google News
Sanofi Ends Marketing Deal With Developer of Inhaled Insulin - New York Times
marketing - Google News